Final Results of a Phase II Trial Evaluating Trastuzumab and Bevacizumab as First Line Treatment of HER2-Amplified Advanced Breast Cancer.

@inproceedings{Hurvitz2009FinalRO,
  title={Final Results of a Phase II Trial Evaluating Trastuzumab and Bevacizumab as First Line Treatment of HER2-Amplified Advanced Breast Cancer.},
  author={Sara A. Hurvitz and Mark D. Pegram and Li-mei Lin and David Soen-Mun Chan and Hailey Allen and Richard Dichmann and Christopher T. Hagenstad and John L. Barstis and Robert C. Hermann and Eddie H. Hu and R Moroose and Samantha Thomas and Charles Vogel and Nancy Ryba and David Elashoff and Dj Slamon},
  year={2009}
}

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

Drug Resistance and the Role of Combination Chemotherapy in Improving Patient Outcomes

  • International journal of breast cancer
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND